Residual Paralysis and Reversal With Routine Neostigmine Versus Half-dose Sugammadex and Routine Neostigmine

Clinical trial NCT05066035 · COMPLETED

Trial details

NCT number: NCT05066035
Sponsor: Kartal Kosuyolu Yuksek Ihtisas Education and Research Hospital
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Neuromuscular Blockade Sugammadex Neostigmine Complication of Anesthesia Postoperative Residual Curarization Rocuronium

Start date: 2013-05-01
Primary completion: 2016-10-01
Enrollment: 113

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.